TY - BOOK ID - 61372726 TI - Challenges to tackling antimicrobial resistance : economic and policy responses AU - Anderson, Michael AU - Cecchini, Michele AU - Mossialos, Elias PY - 2019 SN - 1108864120 1108799450 1108873758 1108874827 PB - Cambridge : Cambridge University Press, DB - UniCat KW - Drug resistance. KW - Drug development. KW - Development of drugs KW - Drugs KW - New drug development KW - Pharmacology KW - Pharmacy KW - Resistance to drugs KW - Development KW - health systems KW - health policies KW - health administration KW - health economics KW - health management KW - public policy KW - agricultural sciences KW - epidemiology KW - superbugs KW - antibiotic resistance KW - drug resistance KW - antiobiotic stewardship UR - https://www.unicat.be/uniCat?func=search&query=sysid:61372726 AB - Antimicrobial resistance (AMR) is a biological mechanism whereby a micro-organism evolves over time to develop the ability to become resistant to antimicrobial therapies such as antibiotics. The drivers of and potential solutions to AMR are complex, often spanning multiple sectors. The internationally recognised response to AMR advocates for a 'One Health' approach, which requires policies to be developed and implemented across human, animal, and environmental health. To date, misaligned economic incentives have slowed the development of novel antimicrobials and limited efforts to reduce antimicrobial usage. However, the research which underpins the variety of policy options to tackle AMR is rapidly evolving across multiple disciplines such as human medicine, veterinary medicine, agricultural sciences, epidemiology, economics, sociology and psychology. By bringing together in one place the latest evidence and analysing the different facets of the complex problem of tackling AMR, this book offers an accessible summary for policy-makers, academics and students on the big questions around AMR policy. ER -